TY - JOUR
T1 - Heart rhythm disturbances in the neonatal alloxan-induced diabetic rat
AU - Howarth, Frank Christopher
AU - Shafiullah, Mohamed
AU - Adeghate, Ernest
AU - Ljubisavljevic, Milos
AU - Jacobson, Michael
N1 - Funding Information:
This project was supported by an Individual Grant from the United Arab Emirates University, Al Ain, United Arab Emirates .
PY - 2011/6
Y1 - 2011/6
N2 - Diabetic patients show a higher incidence of cardiac arrhythmias, including ventricular fibrillation and sudden death. Their electrocardiograms may show several alterations from normal patterns, many of them related to the QT. Various diastolic and systolic abnormalities are frequently reported in diabetic patients, and the severity of the abnormalities depend on the patients' age and the duration of diabetes. The aim of this experimental study has been to clarify the progressive effects on heart rhythm in neonatal alloxan (ALX) (induced at 5 days of age) diabetic male rats. Cardiac biopotential data were acquired in vivo with a biotelemetry system. After an overnight fast blood glucose in diabetic rats, compared to age-matched controls, was elevated before and at 60, 120 and 180. min after a glucose challenge at 2 and 8 months of age. Heart rate and heart rate variability were modestly reduced and QT interval modestly prolonged in diabetic rats, compared to controls, at 2, 6 and 8 months of age. There was also an age-dependent decline in heart rate and prolongation in QT interval. At 8 months heart rate was 296 ± 8. bpm in diabetic compared to 311 ± 10. bpm in controls and heart rate variability was 27 ± 3. bpm in diabetic rats compared to 32 ± 4. bpm in controls. Physical activity was significantly reduced in diabetic rats, compared to controls, at 6 and 8 months of age. Body temperature was modestly reduced in diabetic rats, compared to controls, at 2, 6 and 8 months. In conclusion, the neonatal ALX-induced diabetes mellitus was associated with disturbances in heart rate, heart rate variability, QT interval which in turn may be associated with changes in physical activity and body temperature.
AB - Diabetic patients show a higher incidence of cardiac arrhythmias, including ventricular fibrillation and sudden death. Their electrocardiograms may show several alterations from normal patterns, many of them related to the QT. Various diastolic and systolic abnormalities are frequently reported in diabetic patients, and the severity of the abnormalities depend on the patients' age and the duration of diabetes. The aim of this experimental study has been to clarify the progressive effects on heart rhythm in neonatal alloxan (ALX) (induced at 5 days of age) diabetic male rats. Cardiac biopotential data were acquired in vivo with a biotelemetry system. After an overnight fast blood glucose in diabetic rats, compared to age-matched controls, was elevated before and at 60, 120 and 180. min after a glucose challenge at 2 and 8 months of age. Heart rate and heart rate variability were modestly reduced and QT interval modestly prolonged in diabetic rats, compared to controls, at 2, 6 and 8 months of age. There was also an age-dependent decline in heart rate and prolongation in QT interval. At 8 months heart rate was 296 ± 8. bpm in diabetic compared to 311 ± 10. bpm in controls and heart rate variability was 27 ± 3. bpm in diabetic rats compared to 32 ± 4. bpm in controls. Physical activity was significantly reduced in diabetic rats, compared to controls, at 6 and 8 months of age. Body temperature was modestly reduced in diabetic rats, compared to controls, at 2, 6 and 8 months. In conclusion, the neonatal ALX-induced diabetes mellitus was associated with disturbances in heart rate, heart rate variability, QT interval which in turn may be associated with changes in physical activity and body temperature.
KW - Body temperature
KW - Heart rate
KW - Heart rate variability
KW - Male rats
KW - Neonatal alloxan-induced diabetes mellitus
KW - Physical activity
KW - QT interval
UR - http://www.scopus.com/inward/record.url?scp=79954571020&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79954571020&partnerID=8YFLogxK
U2 - 10.1016/j.pathophys.2010.10.001
DO - 10.1016/j.pathophys.2010.10.001
M3 - Article
C2 - 21051208
AN - SCOPUS:79954571020
SN - 0928-4680
VL - 18
SP - 185
EP - 192
JO - Pathophysiology
JF - Pathophysiology
IS - 3
ER -